Index of suspicion.
Reirden
Daniel H
DH
The University of Colorado Denver School of Medicine, The Children's Hospital, Aurora, Colo., USA.
Menchise
Alexandra N
AN
Knox
Brian
B
Gereige
Rani
R
Howard
Tamara
T
Thomas
Erica L
EL
Connelly
Rosina
R
Tyler
Sarah
S
McPeak
Katie
K
D000038:Abscess / Q000188:drug therapy / Q000382:microbiology; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002006:Brucellosis / Q000175:diagnosis* / Q000188:drug therapy; D002444:Cefuroxime / Q000627:therapeutic use; D002648:Child; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007592:Joint Diseases / Q000382:microbiology*; D007674:Kidney Diseases / Q000188:drug therapy / Q000382:microbiology; D008193:Lyme Disease / Q000175:diagnosis / Q000276:immunology; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D010146:Pain; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007074:Immunoglobulin G; D004318:Doxycycline; D002444:Cefuroxime; D012293:Rifampin